Pharos IBio Co (XKRX:388870) Operating Cash Flow per Share : ₩-677.72 (TTM As of Mar. 2025)

View and export this data going back to 2023. Start your Free Trial

What is Pharos IBio Co Operating Cash Flow per Share?

Pharos IBio Co's operating cash flow per share for the three months ended in Mar. 2025 was ₩-213.30. Pharos IBio Co's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2025 was ₩-677.72.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 17.00% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -3.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Pharos IBio Co's Operating Cash Flow per Share or its related term are showing as below:

XKRX:388870' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -30.8 Med: 13.2 Max: 17
Current: 17

During the past 6 years, Pharos IBio Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 17.00% per year. The lowest was -30.80% per year. And the median was 13.20% per year.

XKRX:388870's 3-Year OCF Growth Rate is ranked better than
58.72% of 1221 companies
in the Biotechnology industry
Industry Median: 9.3 vs XKRX:388870: 17.00

Pharos IBio Co Operating Cash Flow per Share Historical Data

The historical data trend for Pharos IBio Co's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharos IBio Co Operating Cash Flow per Share Chart

Pharos IBio Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Operating Cash Flow per Share

Get a 7-Day Free Trial

-935.23

-1,261.28

-921.41

-612.55

-721.60

Pharos IBio Co Quarterly Data
	Dec19	Dec20	Dec21	Mar22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Operating Cash Flow per Share	Get a 7-Day Free Trial										-257.42	-207.32	-136.37	-120.73	-213.30

Competitive Comparison of Pharos IBio Co's Operating Cash Flow per Share

For the Biotechnology subindustry, Pharos IBio Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharos IBio Co's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharos IBio Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Pharos IBio Co's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Pharos IBio Co Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Pharos IBio Co's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (A: Dec. 2024 )	=	Cash Flow from Operations (A: Dec. 2024 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2024 )
	=	-9327.343	/	12.926
	=	-721.60

Pharos IBio Co's Operating Cash Flow per Share for the quarter that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (Q: Mar. 2025 )	=	Cash Flow from Operations (Q: Mar. 2025 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2025 )
	=	-2763.9	/	12.958
	=	-213.30

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-677.72

Pharos IBio Co Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Pharos IBio Co's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharos IBio Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharos IBio Co Ltd (XKRX:388870) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

427beon-gil, Dongan-gu, 1407 and 1408, 38, Heungan-daero, Seongji Star With, Gyeonggi-do, Gwanyang-dong, Anyang-si, KOR

Website

https://www.pharosibio.com

Pharos IBio Co Ltd is a company specializing in new drug development that develops treatments for rare and intractable diseases. It utilizes a new drug development platform based on big data and AI technology. Its product candidate comprises PHI-101-AML, a treatment drug for refractory/relapsed acute myeloid leukemia; PHI-101-OC developed for platinum-resistant/refractory ovarian cancer patients; PHI-101-TNBC is being developed as a drug to treat metastatic triple-negative breast cancer (TNBC); PHI-201; PHI-301; and PHI-501.

Pharos IBio Co Headlines

No Headlines